tiprankstipranks
Trending News
More News >
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market
Advertisement

GlucoTrack (GCTK) Technical Analysis

Compare
237 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
GlucoTrack’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting GlucoTrack is a Buy.
GlucoTrack’s (GCTK) 20-Day exponential moving average is 6.52, while GlucoTrack’s (GCTK) share price is $5.75, making it a Sell.
GlucoTrack’s (GCTK) 50-Day exponential moving average is 6.71, while GlucoTrack’s (GCTK) share price is $5.75, making it a Sell.

GlucoTrack (GCTK) Pivot Points

Nov 08, 2025, 07:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.72
5.81
5.92
6.00
6.12
6.20
6.31
Fibonacci
5.81
5.88
5.93
6.00
6.08
6.12
6.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

Nov 08, 2025, 07:58 AM
Period
Simple
Exponential
MA5
6.16Sell
6.09Sell
MA10
6.42Sell
6.32Sell
MA20
6.69Sell
6.52Sell
MA50
6.47Sell
6.71Sell
MA100
6.28Sell
16.42Sell
MA200
14.21Sell
66.01Sell
GlucoTrack’s (GCTK) 10-Day exponential moving average is 6.32, while GlucoTrack’s (GCTK) share price is $5.75, making it a Sell.
GlucoTrack’s (GCTK) 100-Day exponential moving average is 16.42, while GlucoTrack’s (GCTK) share price is $5.75, making it a Sell.
GlucoTrack’s (GCTK) stock price is $5.75 and GlucoTrack’s (GCTK) 50-day simple moving average is 6.47, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $5.75 and GlucoTrack’s (GCTK) 100-day simple moving average is 6.28, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $5.75 and GlucoTrack’s (GCTK) 200-day simple moving average is 14.21, creating a Sell signal.

GlucoTrack (GCTK) Technical Indicators

Nov 08, 2025, 07:58 AM
Name
Value
Implied Action
RSI (14)
39.47
Neutral
STOCH (9,6)
4.99
Buy
STOCHRSI (14)
4.99
Buy
MACD (12,26)
-0.18
Buy
ADX (14)
23.79
Neutral
Williams %R
-93.68
Buy
CCI (14)
-162.25
Buy
ATR (14)
0.51
-
Ultimate Oscillator
35.37
Neutral
ROC
-13.66
Sell
GlucoTrack’s (GCTK) Relative Strength Index (RSI) is 39.47, creating a Neutral signal.
GlucoTrack’s (GCTK) Trend Strength Indicator (ADX) is 23.79, creating a Neutral signal.
GlucoTrack’s (GCTK) Commodity Channel Index (CCI) is -162.25, creating a Buy signal.
GlucoTrack’s (GCTK) Price Rate of Change (ROC) is -13.66, creating a Sell signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Sell.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 39.47, which suggests GCTK is a Neutral.
      What is GCTK’s MACD?
      GCTK’s MACD is -0.18, which suggests GCTK is a Buy.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 6.16, which suggests GCTK is a Sell.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 6.69, which suggests GCTK is a Sell.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 6.47, which suggests GCTK is a Sell.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 14.21, which suggests GCTK is a Sell.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -93.68, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is -162.25, which suggests GCTK is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis